Clinical and economic assessment of using IRS®19 for the treatment and prevention of acute respiratory infections in children

Objective: to perform pharmacoeconomic analysis of the feasibility of using topical bacterial lysate in the form of nasal spray (IRS®19) for the treatment and prevention of upper respiratory tract infections in pediatric population in comparison with other drugs registered in Russia, belonging to th...

Full description

Saved in:
Bibliographic Details
Main Authors: A. S. Kolbin, A. R. Kasimova
Format: Article
Language:Russian
Published: IRBIS LLC 2024-08-01
Series:Фармакоэкономика
Subjects:
Online Access:https://www.pharmacoeconomics.ru/jour/article/view/1036
Tags: Add Tag
No Tags, Be the first to tag this record!